Adipose tissue, insulin action and vascular disease: Inflammatory signals

International Journal of Obesity

Volumn 27, Issue SUPPL. 3, 2003, Pages

  Yudkin, J S ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Archway Wing ^*  (United Kingdom)

Author keywords

C reactive protein; Cardiovascular risk; Dyslipidaemia; Endothelial dysfunction; Inflammation; Insulin resistance; Interleukin 6; Metabolic syndrome; Proinflammatory cytokines; Signalling

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AUTOCRINE EFFECT; CARDIOVASCULAR RISK; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIUM CELL; FIBRINOGEN BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; MICROALBUMINURIA; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULAR DISEASE;

ADIPOSE TISSUE; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INSULIN RESISTANCE; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 0346250163     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802346     Document Type: Conference Paper

References (22)

1. Reaven GM. Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 1988; 37: 1595-1607.
2. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989; 84: 205-213.
3. Panahloo A, Yudkin JS. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease. Coronary Artery Dis 1996; 7: 723-731.
4. Foyle W-J, Carstensen E, Fernandez M, Yudkin JS. A longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium countertransport in non-diabetic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 1330-1337.
5. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - evidence against a modulating role for insulin. Diabetologia 1995; 38: 1110-1116.
6. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
7. Metcalf PA, Scragg RK, Dryson E. Associations between body morphology and microalbuminuria in healthy middle-aged European, Maori and Pacific Island New Zealanders. Int J Obes Relat Metab Disord 1997; 21: 203-210.
8. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
9. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, Bosello O, Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999; 23: 936-942.
10. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-809.
11. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002; 161: 233-242.
12. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A, on behalf of the HIFMECH Study Group. The insulin resistance syndrome and inflammatory markers in relation to myocardial infarction in the north and south of Europe (HIFMECH Study). Submitted for publication.
13. Ijzerman RG, Voordouw JJ, van Weissenbruch MM, Yudkin JS, Serné EH, Delemarre-van de Waal HA, Stehouwer CDA. TNF-α is associated with skin capillary recruitment: a potential explanation for the relationship between TNF-α and insulin resistance. Submitted for publication.
14. Mohamed-Ali V, Goodrick S, Rawesh A, Katz D, Miles JM, Katz DR, Yudkin JS, Coppack SW. Subcutaneous adipose tissue secretes interleukin-6 but not tumour necrosis factor-α in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
15. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14: 263-283.
16. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995; 26: 764-770.
17. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
18. Yudkin JS, Kumari M, Humphries S, Mohamed-Ali V, on behalf of the University College London Interleukin-6 Group. Interleukin-6: a proinflammatory cytokine linking inflammation, obesity, stress, ethnicity, and coronary heart disease? Atherosclerosis 2000; 148: 209-214.
19. Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 1998; 27: 1296-1303.
20. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999; 19: 2364-2367.
21. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-953.
22. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409: 729-733.